International Biotechnology Trust (LSE:IBT) Total Stockholders Equity: £315.36 Mil (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:IBT International Biotechnology Trust PLC LSE:IBT
29 GF Score
Price £11.35
! 4 Warning Signs
View Full Analysis

What is International Biotechnology Trust Total Stockholders Equity?

International Biotechnology Trust LSE:IBT +0.44% 29 Total Stockholders Equity is £315.36 Mil as of Feb. 2026. GuruFocus rates LSE:IBT with a GF Score™ of 29/100. The stock has 4 warning signs investors should review.

International Biotechnology Trust's Total Stockholders Equity for the quarter that ended in Feb. 2026 was £315.36 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. International Biotechnology Trust's Book Value per Share for the quarter that ended in Feb. 2026 was £9.88. The ratio of a company's debt over equity can be used to measure how leveraged this company is. International Biotechnology Trust's Debt-to-Equity for the quarter that ended in Feb. 2026 was 0.10.

International Biotechnology Trust  (LSE:IBT) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

International Biotechnology Trust's Book Value per Share for the quarter that ended in Feb. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(315.361-0)/31.903
=9.88

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

International Biotechnology Trust's Debt-to-Equity for the quarter that ended in Feb. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 31.963) / 315.361
=0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

International Biotechnology Trust Total Stockholders Equity Related Terms

International Biotechnology Trust Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for International Biotechnology Trust's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

International Biotechnology Trust Total Stockholders Equity Chart

International Biotechnology Trust Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 323.78 284.89 270.32 282.27 249.41

International Biotechnology Trust Semi-Annual Data
Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 286.51 282.27 274.58 249.41 315.36
LSE:IBT
29GF Score
International Biotechnology Trust PLC LSE:IBT
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of £315.36 Mil mean?
International Biotechnology Trust (LSE:IBT) has a Total Stockholders Equity of £315.36 Mil as of Feb. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for International Biotechnology Trust and its competitors.
Is International Biotechnology Trust's Total Stockholders Equity too high?
International Biotechnology Trust's current Total Stockholders Equity is £315.36 Mil. Overall, International Biotechnology Trust has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does International Biotechnology Trust's Total Stockholders Equity compare to VRTX and REGN?
International Biotechnology Trust's Total Stockholders Equity of £315.36 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Biotechnology company?
A good Total Stockholders Equity depends on the Biotechnology industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for International Biotechnology Trust and its competitors. International Biotechnology Trust's current Total Stockholders Equity is £315.36 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is International Biotechnology Trust stock overvalued right now?
International Biotechnology Trust (LSE:IBT) has a current Total Stockholders Equity of £315.36 Mil. The current Total Stockholders Equity is £315.36 Mil. International Biotechnology Trust's overall GF Score™ is 29/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For International Biotechnology Trust (LSE:IBT), the current Total Stockholders Equity is £315.36 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

International Biotechnology Trust Business Description

Address 1 London Wall Place, London, GBR, EC2Y 5AU
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments ,and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.
29GF Score

Get the complete analysis for LSE:IBT

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£11.35
Price